Plasma-Based Genotyping Pays Off in NSCLC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2018-142
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Combined Plasma and Tissue Genotyping of EGFR T790M Benefits NSCLC Patients:A Real‐world Clinical Example

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Lab Profile: Collaboration Pays Off for NCSR

Analytical Chemistry
Analytical Chemistry
2001English

MINI01.02: Response and Plasma Genotyping From Phase I/Ii Trial of Ensartinib (X-396) in Patients (Pts) With ALK+ NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Extracellular Vesicle-Derived DNA for Performing EGFR Genotyping of NSCLC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Quality Pays Off: Don't Ask This Man to Compromise.

Chemical and Engineering News
Chemical Engineering
1975English

No Monkey Business: Why Studying NK Cells in Non-Human Primates Pays Off

Frontiers in Immunology
AllergyImmunology
2013English

Why Early Collective Action Pays Off: Evidence From Setting Protected Geographical Indications – CORRIGENDUM

Renewable Agriculture and Food Systems
AgronomyCrop ScienceFood Science
2016English

Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P3.09-16 Transcriptome Profiling for Subtyping NSCLC: Off the Beaten Path(Ologist)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy